Acceder

Publicaciones - TRASPLANTE HEMATOPOYÉTICO / TERAPIA CELULAR

Cargando...
Soler-Espejo E, Marin F, Lopez-Galvez R, Ramos-Bratos MP, Sanchez-Villalobos M, Esteve-Pastor MA, Lip GYH, Rivera-Caravaca JM, Roldan V. The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort Study. Clin Cardiol. 2025 Feb;48(2):e70102. doi: 10.1002/clc.70102. PubMed PMID: 39985306; PubMed Central PMCID: PMC11845907.
AÑO: 2025; IF: 2.3
39985306
Alcaraz M, Hernandez-Marmol I, Puente-Cuadrado JM, Rodriguez-Valiente M, Silini AR, Parolini O, Nicolas FJ. Distinct roles of amniotic membrane epithelial (hAEC) and mesenchymal stromal cells (hAMSC) in amniotic membrane-driven wound healing. Sci Rep. 2025 Oct 21;15(1):36806. doi: 10.1038/s41598-025-20685-4. PubMed PMID: 41120712.
AÑO: 2025; IF: 3.9
41120712
Soler-Espejo E, Chen Y, Rivera-Caravaca JM, Sanchez-Salas JA, Esteve-Pastor MA, Marin F, Roldan V, Lip GYH. Relation of the stress hyperglycaemia ratio to residual risk in anticoagulated patients with atrial fibrillation: A report from the prospective Murcia AF Project III cohort. Diabetes Obes Metab. 2025 Dec 4. doi: 10.1111/dom.70335. Online ahead of print. PubMed PMID: 41342100.
AÑO: 2025; IF: 5.7
41342100
Soler-Espejo E, Ramos-Bratos MP, Gonzalez-Lozano E, Lip GYH, Marin F, Rivera-Caravaca JM, Roldan V. Association between baseline adherence to a healthy lifestyle with ischemic and major cardiovascular events in patients with atrial fibrillation. Eur J Prev Cardiol. 2025 May 14:zwaf287. doi: 10.1093/eurjpc/zwaf287. Online ahead of print. PubMed PMID: 40366897.
AÑO: 2025; IF: 7.5
40366897
Perez-Guzman N, Garcia-Rios P, Rodriguez-Lozano FJ, Garcia-Bernal D, El Yahyaoui A, Lopez-Garcia S. Ultrastructural and immunobiological responses of human periodontal ligament stem cells to novel tricalcium silicate sealers. Dent Mater. 2025 Oct 29:S0109-5641(25)00800-0. doi: 10.1016/j.dental.2025.10.011. Online ahead of print. PubMed PMID: 41168012.
AÑO: 2025; IF: 6.3
41168012
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

TRASPLANTE HEMATOPOYÉTICO / TERAPIA CELULAR